A significant breakthrough in cancer research is emerging with the use of VHH fragments to re-engage mutated p53. This crucial malignant inhibitor protein is frequently lost in many forms of malignancies, causing https://ezmarkbookmarks.com/story22078058/nanobodies-revive-tumor-suppressor-p53-a-promising-hope-for-cancer-management